ERO1A and neoplasm: In addition, ERO1A mRNA level was negatively correlated with genes that define anti-tumor immunity and immune infiltrates, including CD8+ T, B, and NK cells, whereas it was positively correlated with CD4+ T cells (Figures S4A–S4D).